Startseite Kongressberichte 2020 Virtual Edition of the 25th Annual Congress of the European Hematology Association Oral Sessions Immunology Stem cell transplantation: Stem cell transplantation:

Stem cell transplantation - Clinical: Other Complications

 
Yaqiong Tang, Jia Chen, Tiantian Chu, et al.
 
The authors of the abstract conclude: 
Decitabine effectively facilitated platelet recovery in HCT-RPIT patients, presumably by promoting the repair and reconstitution of megakaryocytes and marrow endothelial cells. 
————————————————————————————————————————————————————————
 
 
Masamichi Isobe, Takaaki Konuma, Masayoshi Masuko, et al.
 
The authors of the abstract conclude: 
Although the risks of engraftment failure and early NRM were not low, single CBT could be effective treatment option for AML patients aged 60 years or older.
————————————————————————————————————————————————————————
 
 
Alessandro Rambaldi, Mark Smith, Steve Whitaker, Samer Khaled
 
The authors of the abstract conclude: 
In this trial, most narsoplimab-treated patients achieved a complete response with a significant improvement in laboratory markers and in clinical status. No safety signal was observed.
————————————————————————————————————————————————————————
 
 
xing-ye meng, hai-xia fu, xiao liu, et al.
 
The authors of the abstract conclude: 
CMV viral load and refractory CMV infection played an important role in CMV diseases. The mortality after the diagnosis of CMVP, Di-CMVD and CMVE was higher than that of CMVG and CMVR. Besides, CMVP, CMVR and CMVE were associated with increased mortality independently.
————————————————————————————————————————————————————————
 
 
Antonio Pierini, Loredana Ruggeri, Carotti Alessandra, et al.
 
The authors of the abstract conclude: 
A haploidentical transplantation protocol that combined an age-adjusted myeloablative conditioning regimen with Treg/Tcon adoptive immunotherapy provided an unprecedented 78% chronic GvHD/relapse-free survival in 50 AML patients despite 31 were 50 to 65  years-old.